Latest Breaking News On - Luye pharma international - Page 1 : comparemela.com

Luye Pharma s Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao

Luye Pharma s Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao
balticbusinessnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balticbusinessnews.com Daily Mail and Mail on Sunday newspapers.

Macau generalHong kongUniversity of hong kongHong kong generalUniversitario gregorio maraHerbert loongAntonio callesLuye pharmaChinese university of hong kongLuye pharma internationalDrug administrationLuye pharma groupHong kong cancer therapy societyFirst hospital of sun yat sen universityDepartment of clinical oncologyDepartment of medical oncology at hospital

Luye Pharma and Duopharma Reach Strategic Partnership to Expand Accessibility of Cholesterol Management Products in Malaysia

Luye Pharma and Duopharma Reach Strategic Partnership to Expand Accessibility of Cholesterol Management Products in Malaysia
vietreader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vietreader.com Daily Mail and Mail on Sunday newspapers.

Jakarta rayaKuala lumpurLuye pharmaSdn bhdDuopharmam sendirian berhadBerhad duopharmaLuye pharma groupDuopharma biotech groupDuopharma biotech strategic partnership signing ceremonyResearch developmentLuye pharma internationalPrnewswire luye pharma groupPharma groupDuopharma marketing sdn bhdDuopharma biotech berhadDuopharma biotech

Duopharm to market Luye s cholesterol management product

Luye Pharma Group has signed a marketing and distribution agreement with Duopharma Marketing for a cholesterol management product in Malaysia.

Abdul shatarLuye pharmaLuye pharma internationalDuopharma biotech groupLuye pharma groupDuopharma biotechPharma groupDuopharma marketingBiotech groupLeonard ariff abdul shatarAndy siow

Luye Pharma s Innovative Anti-Cancer Therapy Lurbinectedin to Benefit Named Patients in Hong Kong

HONG KONG, Jan. 9, 2023 /PRNewswire/ Luye Pharma s Innovative Anti-Cancer Therapy Lurbinectedin to Benefit

Hong kongUniversity of hong kongHong kong generalWilliam vanLuye pharmaLeung kwong chuenLuye pharma groupPatient program of lurbinectedinAbacus medicine pharma services asiaDrug administrationAbacus medicine groupLuye pharma internationalHong kong precision oncology societyPrnewswire luye pharma groupAbacus medicine pharma servicesPatient program

Luye Pharma Enters Local Seroquel® Distribution and Marketing Partnership with ICI Pakistan Limited

"We Care About Mental Health" awareness set to increase across APAC SHANGHAI, Sept. 27, 2022 /PRNewswire/ Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications has entered a distribution and marketing partnership with ICI Pakistan Limited, a leading manufacturing and trading company based in Pakistan. According to the terms.

Sadiq naveedAamer malikLuye pharmaAsia pacificYehong zhangWali masoodRukhsana nawazLuye pharma groupYunus brothers groupChemicals agri sciencesMorinaga milk industry coWe care about mental healthNutrico morinaga privateLuye pharma internationalPrnewswire luye pharma groupPakistan limited pharmaceuticals